Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How do you image when using DIBH with breast treatment?
Do you use portal or orthogonal imaging or both?
Answer from: Radiation Oncologist at Community Practice
For patients undergoing DIBH we use standard portal imaging only.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
VisionRT/OSMS daily with weekly standard ports
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
We use daily imaging of one tangential field . To minimize dose and exposure we only take one image of actual field and not double exposure with open field
Sign in or Register to read more
5160
5179
5178
Related Questions
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
Would you offer APBI to a patient with very large breast anatomy and a small lumpectomy cavity after an oncoplastic closure?
Would you recommend PMRT in a patient with a triple negative cT2N0, ypT2N0 metaplastic breast cancer s/p NAC, mastectomy, and SLNB?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
Do you start systemic therapy for patients with previously localized HR+ breast cancer developing solitary bone metastasis which is now triple negative if there are no other sites of disease after metastasis-directed radiation?
When do you consider the addition of concurrent pembrolizumab to breast irradiation?
Should PMRT be offered for ypN0(i+) disease if only 1-2 nodes were removed in the post-chemotherapy SLNB and there is no plan for a completion AxLND?
In cT4aN0 triple negative breast cancer would you still recommend PMRT if pCR, ypT0N0(sn), after neoadj chemo is achieved?
What volumes would you cover in a young patient with otherwise low risk breast cancer in whom the sentinel node failed to map and ALND was not performed?